Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 11,572,640 | 10,040,030 | 9,978,452 | 6,661,317 | 10,543,880 |
| Cost of Goods | 4,001,409 | 3,390,391 | 3,559,732 | 2,460,776 | 3,434,708 |
| Gross Profit | 7,571,234 | 6,649,641 | 6,418,720 | 4,200,540 | 7,109,168 |
| Operating Expenses | 4,924,178 | 4,742,052 | 4,559,482 | 2,832,881 | 4,621,146 |
| Operating Income | 2,647,466 | 1,907,979 | 1,859,970 | 1,368,437 | 2,488,730 |
| Interest Expense | 302,110 | 304,711 | 291,760 | 183,816 | 303,599 |
| Other Income | 60,422 | 21,857 | 118,528 | 21,388 | 36,484 |
| Pre-tax Income | 2,405,778 | 1,625,125 | 1,686,738 | 1,206,009 | 2,221,615 |
| Income Tax | 289,779 | 275,140 | 403,775 | -108,138 | 251,479 |
| Net Income Continuous | 2,116,000 | 1,349,985 | 1,282,963 | 1,314,148 | 1,970,136 |
| Minority Interests | 202,228 | 110,570 | 201,888 | -10,811 | 122,482 |
| Net Income | $1,913,771 | $1,239,415 | $1,081,075 | $1,324,959 | $1,847,654 |
| EPS Basic Total Ops | 0.97 | 0.63 | 0.55 | 0.83 | 0.94 |
| EPS Basic Continuous Ops | 1.07 | 0.68 | 0.65 | 0.67 | 1.00 |
| EPS Diluted Total Ops | 0.96 | 0.62 | 0.54 | 0.82 | 0.93 |
| EPS Diluted Continuous Ops | 1.06 | 0.68 | 0.64 | 0.65 | 1.00 |
| EBITDA(a) | $3,177,003 | $2,885,808 | $3,400,827 | $2,322,618 | $3,095,984 |